Expert Review of Vaccines
Volume 21, 2022 - Issue 6
Review
Correlates of protection for meningococcal surface protein vaccines: lessons from the past
Jamie Findlowa Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer Ltd, Tadworth, UKCorrespondence[email protected]
https://orcid.org/0000-0001-5153-4043View further author information
https://orcid.org/0000-0001-5153-4043View further author information, Jay Lucidarmeb Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, UKhttps://orcid.org/0000-0001-5553-2512View further author information
https://orcid.org/0000-0001-5553-2512View further author information, Muhamed-Kheir Tahac Invasive Bacterial Infections Unit, Institute Pasteur, Paris, Francehttps://orcid.org/0000-0002-0716-3174View further author information
https://orcid.org/0000-0002-0716-3174View further author information, & Paul Balmerd Vaccine Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, PA, USAhttps://orcid.org/0000-0001-8188-1791View further author information
https://orcid.org/0000-0001-8188-1791View further author information